Kala Pharmaceuticals to Present at Upcoming Investor Conferences in March

WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in March. H.C. Wainwright Global Life Sciences Conference Date: March 9-10, 2021 Pre-recorded presentation will be made available beginning Tuesday, March 9, 2021 at 7:00 am ET Op